Ryang S, Kim SS, Bae JC, Han JM, et al. A Double-blind, Randomized Controlled Trial on Glucose-lowering Effects and Safety of Adding 0.25 or 0.5 mg Lobeglitazone in Type 2 Diabetes Patients with Inadequate Control on Metformin and DPP-4 Inhibitor Therapy: REFIND Study. Diabetes Obes Metab 2022 May 17. doi: 10.1111/dom.14766.
PMID: 35581902